In this study, three of the genes in the four‐gene signature showed a prognostic utility for PCa patients in the HTP and GSE220095 datasets, although there are some differences in clinical endpoints across the datasets (e.g., RFS and BCR). This evidence concerns the gene BCR and posterior cortical atrophy.